A CLINICAL TRIAL TO STUDY THE EFFECT OF TRIKATVADI GUGGULU AND GOKSHURADI GUGGULU IN PATIENTS WITH TYPE 2 DIABETES MELLITUS ( PRAMEHA)

AN OPEN LABELLED RANDOMISED CONTROLLED CLINICAL STUDY TO EVALUATE THE EFFECT OF TRIKATVADI GUGGULU IN PRAMEHA W.S.R. TO TYPE II DIABETES MELLITUS - TRIKAT

Status

Active, not recruiting

Phases

Phase 2Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2025/03/082626

Enrollment

Registered

2025-03-18

Start date

Unknown

Completion date

Unknown

Last updated

2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: E119- Type 2 diabetes mellitus without complications

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: Patients fulfilling the following criteria: 1. Fasting blood sugar level between 126mg/dl TO 250mg/dl 2. Post prandial blood sugar level between 200mg/dl to 300mg/dl 3.Subjects who are willing to sign the consent form to participate in the research

Exclusion criteria

Exclusion criteria: 1. Diabetic complications. 2. Any life-threatening disorder interfering with the treatment. 3. Pregnant and lactating women 4. Had participated in any clinical trial within 3 months of screening.

Design outcomes

Primary

Measure	Time frame
Fasting Blood Sugar Level Post Prandial Blood Sugar LevelTimepoint: 14 AND 28 DAYS	—

Secondary

Measure	Time frame
Avila mootrata (Turbidity in urine) Pipasaadhikya (Polydipsia) Kshudaadhikya (polyphagia) Dourbalya (debility) Mukhatalushosha (dryness of oral cavity) Kara padadaha (neuropathy) Kara padasuptata (neuropathy) Shithilangata (fatigue)Timepoint: 14 AND 28 DAYS	—

Countries

India

Contacts

Public ContactDR VEERAKUMARA K

SDM COLLEGE OF AYURVEDA

khadiravana@gmail.com9743490753

Outcome results